Drugs Recalls

17,415 recalls in this category

FDA Drug Class II Terminated

GLUTATHIONE INHALATION 30MG/ML SOLUTION 120 ML, 60 ML; GLUTATHIONE P.F. 200MG/ML INJECTABLE 10 ML, 100 ML, 14 ML, 150 ML, 175 ML, 20 ML, 30 ML, 300 ML, 40 ML, 40 MLS, 50 ML, 58 MLS, 70 ML; GLUTAT

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 47 units units
FDA Drug Class II Terminated

FLUOROURACIL (5-FU) SOLUTION 5% OPHTHALMIC 100 ML; FLUOROURACIL (5-FU) SOLUTION IN ARTIFICIAL TEARS 1% OPHTHALMIC 15 ML; FLUOROURACIL (5-FU) SOLUTION, P.F. 0.001% (10MCG/ML) OPHTHALMIC 20 ML, 30 ML

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 14 units units
FDA Drug Class II Terminated

HYDROGEN PEROXIDE PF 3% INJECTABLE 150 ML, 200 ML, 50 ML, 60 ML (4 DIFFERENT PRODUCTS)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 8 units units
FDA Drug Class II Terminated

HYDROCHLORIC ACID INJECTION 2MG/ML INJECTABLE 400 ML, 60 ML (2 DIFFERENT PRODUCTS)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 6 units units
FDA Drug Class II Terminated

CEFTAZIDIME OPHTHALMIC, P.F. 22.5MG/ML (2.25%) OPHTHALMIC 1 ML, 2ML, 2 MLS, 6 ML CEFTAZIDIME, LYOPHILIZED, OPHTHALMIC KIT 2.25% KIT 1 KIT

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 197 units units
FDA Drug Class II Terminated

HYALURONIDASE / LIDOCAINE 7.1U/9.5MG/ML INJECTABLE 105 ML, 210 ML (6 DIFFERENT PRODUCTS)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 17 units units
FDA Drug Class II Terminated

DMSO/HEPARIN 50%/20,000U/25ML SOLUTION 100 ML, 25 ML; DMSO/HEPARIN 50%/5000U/50ML SOLUTION 300 ML, 400 ML (4 DIFFERENT PRODUCTS)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 8 units units
FDA Drug Class II Terminated

ACETIC ACID, IRRIGATION 3% SOLUTION 500 ML (1 PRODUCT)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 2 units units
FDA Drug Class II Terminated

BUPIVACAINE/LIDOCAINE/METHYLPREDNISOLONE 0.17% / 0.67% / 2.7% INJECTABLE 15 ML, 18.75 ML, 26.25 ML, 37.5 ML, 45 ML; BUPIVACAINE/LIDOCAINE/METHYLPREDNISOLONE 0.22% / 0.88% / 0.88% INJECTABLE 450 ML, 90

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 7 units units
FDA Drug Class II Terminated

CYCLOPENTALATE/PHENYLEPHRINE 1%/2.5% OPHTHALMIC 5 ML (1 PRODUCT)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 1 unit units
FDA Drug Class II Terminated

GLYCERIN 99.5% OPHTHALMIC 10 ML, 5 ML, 7.5 ML; GLYCERIN 100% OPHTHALMIC 15 ML (4 DIFFERENT PRODUCTS)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 4 units units
FDA Drug Class II Terminated

BUPIVACAINE/CLONIDINE/MORPHINE/ZICONOTIDE, P.F. 20MG/400MCG/20MG/1.5MCG/ML INTRA 20 ML (1 PRODUCT)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 1 unit units
FDA Drug Class II Terminated

FLUORESCEIN/INDOCYANINE, LYOPHILIZED 200MG/10MG VIAL INJECTABLE 12 VIAL, 20 VIAL, 24 VIAL; FLUORESCEIN/INDOCYANINE, LYOPHILIZED 200MG/15MG VIAL INJECTABLE 23 VIAL, 25 VIAL, 30 VIAL, 7 VIAL; FLUORESCEI

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 202 units units
FDA Drug Class II Terminated

EPINEPHRINE **(25X1ML AMPULS) 1:1000 1MG/ML INJECTABLE 25 ML; EPINEPHRINE HCL SOLUTION 1% OPHTHALMIC 10 ML, 20 ML; EPIINEPHRINE P.F. (SULFITE-FREE) 1:1,000 (1MG/ML) INJECTABLE 1 ML, 2 ML, 20 ML, 25 M

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 33 units units
FDA Drug Class II Terminated

CYCLOPENT/KETOROLAC/PHENYLEPH/TROPICAMIDE 1%/0.5%/2.5%/1% OPHTHALMIC 70 ML (1 PRODUCT)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 3 units units
FDA Drug Class II Terminated

BUPIVACAINE/FENTANYL IN SODIUM CHLORIDE 0.9% P. F. 30 MG/200 MCG/ML INTRATHECAL 40 ML (1 PRODUCT)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 2 units units
FDA Drug Class II Terminated

ACYCLOVIR OPHTHALMIC 3% OINTMENT 5 GM; ACYCLOVIR OPHTHALMIC 3% SOLUTION 5 ML (2 DIFFERENT PRODUCTS)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 3 units units
FDA Drug Class II Terminated

DROPTAINER STERILE PLASTIC (2 X 7ML) 10 BOTTLE 4 PK (2 DIFFERENT PRODUCTS)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 2 units units
FDA Drug Class II Terminated

BUPIVACAINE HCL & EPINEPHRINE, P.F. 0.25% / 1:200,000 INJECTABLE 900 ML; BUPIVACAINE HCL & EPINEPHRINE, P.F. 0.5% / 1:200,000 INJECTABLE 900 ML; BUPIVACAINE HCL 0.25% INJECTABLE 120 ML,180 ML, 240 ML,

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 79 units units
FDA Drug Class II Terminated

BACLOFEN, P.F. (WITH 0.9% P.F. NORMAL SALINE) 2,000MCG/ML (2MG/ML) INTRATHECAL 40 ML; BACLOFEN, P.F. (WITH 0.9% P.F. NORMAL SALINE) 600MCG/ML INTRATHECAL 40 ML; BACLOFEN, P.F. 1,000MCG/ML (1MG/ML) IN

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 21 units units
FDA Drug Class II Terminated

HYDROXOCOBALAMIN**(VIT B-12) 1000MCG/ML INJECTABLE 30 ML Injectable (4 DIFFERENT PRODUCTS)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 7 units units
FDA Drug Class II Terminated

ASCORBIC ACID (BEET SOURCE) 500MG/ML INJECTABLE 100 ML, 150 ML, 200 ML, 250 ML, 300 ML, 400 ML, 500 ML, 60 ML; ASCORBIC ACID (CORN SOURCE) 500MG/ML INJECTABLE 100 ML; ASCORBIC ACID, 50ML SDPF, VIAL**

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 19 units units
FDA Drug Class II Terminated

FOLIC ACID 10MG/ML INJECTABLE 60 ML (1 PRODUCT)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 2 units units
FDA Drug Class II Terminated

BACTERIOSTATIC SODIUM CHLORIDE 10ML VIAL** 0.9% INJECTABLE 10 ML, 10 MLS, 100 ML, 120, 20 MLS, 200 ML, 30 MLS, 40 ML, 50 ML, 50 MLS (10 DIFFERENT PRODUCTS)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 27 units units
FDA Drug Class II Terminated

ACETAZOLAMIDE, LYOPHILIZED 500MG INJECTABLE10 VIAL, 4 VIAL, 5 VIAL, 6 VIAL, 8 VIAL (5 DIFFERENT PRODUCTS)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 10 units units
FDA Drug Class II Terminated

CLINDAMYCIN OPHTHALMIC (PF) 20MG/ML (2MG/0.1ML) SOLUTION 2 ML; CLINDAMYCIN PHOSPHATE OPHTHALMIC, INTRAVITREAL (P.F.) 1MG/0.1ML INJECTABLE 0.2 ML; CLINDAMYCIN PHOSPHATE SDPF- (0.1ML SYRINGE,30G,1/2")

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 5 units units
FDA Drug Class II Terminated

HYALURONIC ACID SODIUM SALT 10MG/ML INJECTABLE 100 ML, 20 ML; HYALURONIC ACID SODIUM SALT, P.F. 20MG/ML INJECTABLE 500 ML (3 DIFFERENT PRODUCTS)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 3 units units
FDA Drug Class II Terminated

DEXAMETHASONE SODIUM PHOSPHATE PF 0.04% OPHTHALMIC 2 ML; DEXAMETHASONE / LIDOCAINE 0.5%/3% INJECTABLE 30 MLS; DEXAMETHASONE ACETATE (LA) 8MG/ML INJECTABLE 100 ML; DEXAMETHASONE IONTOPHORESIS, STER

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 73 units units
FDA Drug Class II Terminated

BUPIVACAINE/MORPHINE SULFATE, P.F. 2.5MG/10MG/ML INTRATHECAL 40 ML; BUPIVACAINE/MORPHINE SULFATE, P.F. 7.5MG/25MG/ML INTRATHECAL 20 ML; BUPIVACAINE/MORPHINE SULFATE, P.F. 7.5MG/50MG/ML INTRATHECAL 18

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 16 units units
FDA Drug Class II Terminated

HUMULIN-R INSULIN, 10ML VIAL** 100U/ML INJECTABLE 10 MLS (1 PRODUCT)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 1 unit units
FDA Drug Class II Terminated

AMIKACIN P. F. 250MG/ML INJECTABLE 2 ML,4 ML; AMIKACIN SULFATE**** 4ML SDV 250MG/ML INJECTABLE 40 ML; AMIKACIN SULFATE, LYOPHILIZED 4MG VIAL INJECTABLE 1 KIT,1 VIAL, 2 KIT, 2 KITS, 2 VIAL, 4 KIT, 4 V

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 42 units units
FDA Drug Class II Terminated

BIMIX 30MG / 4MG INJECTABLE 10 ML, 5 ML; BIMIX 30MG / 5MG INJECTABLE 10 ML; BIMIX 9MG / 0.25MG INJECTABLE 10 ML, 5 ML; BIMIX 15MG / 1MG INJECTABLE 10 ML; BIMIX 18MG / 0.5MG INJECTABLE 10 ML, 5

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 448 units units
FDA Drug Class II Terminated

CISPLATIN 1MG/ML INJECTABLE 1000 ML, 2000 ML (2 DIFFERENT PRODUCTS)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 3 units units
FDA Drug Class II Terminated

BUPIVACAINE/HYDROMORPHONE, P.F. 15MG/40MG/ML INTRATHECAL 40 ML; BUPIVACAINE/HYDROMORPHONE, P.F. 22MG/30MG/ML INTRATHECAL 40 ML; BUPIVACAINE/HYDROMORPHONE, P.F. 7.5MG/20MG/ML INTRATHECAL 40 ML; BUPIVAC

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 15 units units
FDA Drug Class II Terminated

DIPHENHYDRAMINE 25MG/ML INJECTABLE 90 ML; DIPHENHYDRAMINE 50MG/ML INJECTABLE 10 ML, 100 ML, 108 ML, 120 MLS, 25 ML, 32 ML, 60 ML, 90 ML, 90 MLS; DIPHENHYDRAMINE, SDV, 25X1ML** 50MG/ML INJECTABLE 25 M

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 26 units units
FDA Drug Class II Terminated

DEXAMETHASONE/BACTERIOSTATIC WATER IONTOPHORESIS 0.5MG/5ML(0.1MG/ML) INJECTABL 30 ML (1 PRODUCT) 40 ML DEXAMETHASONE SDPF (0.1ML SYRINGE, 31G, 5/16" ) 0.4

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 1 unit units
FDA Drug Class II Terminated

AMPHOTERICIN B OPHTHALMIC (0.5ML, LL SYRINGE) P.F. 10MCG/0.1ML INJECTABLE 1 ML, 1.5 ML, 2 ML, 2.5 ML, 5 ML; AMPHOTERICIN B OPHTHALMIC 5MCG/0.1ML INJECTABLE, 0.2 ML, 0.4 ML, 3 ML; AMPHOTERICIN B, LYOPH

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 15 units units
FDA Drug Class II Terminated

DMSO / BUPIVACAINE HCL 50%/0.5% INJECTABLE 100 ML, 50 ML; DMSO 100% INJECTABLE 100 ML; DMSO FORTIFIED IRRIGATION - W/O HEPARIN SOLUTION 350 ML; DMSO FORTIFIED IRRIGATION 50%/0.01%/44%/1% SOLUTION 100

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 107 units units
FDA Drug Class II Terminated

BUPIVACAINE/LIDOCAINE 0.11% / 0.44% INJECTABLE 150 ML (1 PRODUCT)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 1 unit units
FDA Drug Class II Terminated

CYCLOSPORINE (A) AQUEOUS (HUMAN) 0.5% OPHTHALMIC 10 ML, 5 ML; CYCLOSPORINE (A) AQUEOUS PF (HUMAN) 0.2% OPHTHALMIC 10 ML; CYCLOSPORINE (A) AQUEOUS PF (HUMAN) 1% OPHTHALMIC 10 ML; CYCLOSPORINE (

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 40 units units
FDA Drug Class II Terminated

AMINOPHYLLINE 20ML, SDV** 500MG (25MG/ML) INJECTABLE 20 ML (1 PRODUCT)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 1 unit units
FDA Drug Class II Terminated

HYDROMORPHONE/CLONIDINE P. F. 120MG/1.3MCG/ML INTRATHECAL 10 ML; HYDROMORPHONE/CLONIDINE P. F. 120MG/1.8MCG/ML INTRATHECAL 10 ML; HYDROMORPHONE/CLONIDINE P. F. 80MG/1.2MCG/ML INTRATHECAL 10 ML (3 DIFF

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 7 units units
FDA Drug Class II Terminated

CHORIONIC GONADOTROPIN (STANDARD) - 21 DAY 200 UNIT VIALS KIT 1 KIT; CHORIONIC GONADOTROPIN (STANDARD) - 45 DAY 200 UNIT VIALS KIT 1 KIT; CHORIONIC GONADOTROPIN (STANDARD)-21 DAY 125 UNIT VIALS KIT 1

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 193 units units
FDA Drug Class II Terminated

EDTA DISODIUM SOLUTION 33.6MG/ML (0.1 MOLAR) OPHTHALMIC 15 ML; EDTA CALCIUM DISODIUM (PRESERVATIVE FREE) 150MG/ML INJECTABLE 100 ML, 2400 ML, 500 ML; EDTA CALCIUM DISODIUM SOLUTION 2% OPHTHALMIC 5

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 28 units units
FDA Drug Class II Terminated

ENGERIX-B, SDV** 20MCG/ML INJECTABLE 1 ML (1 PRODUCT)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 1 unit units
FDA Drug Class II Terminated

ETHYL ALCOHOL 10% INJECTABLE 30 ML; ETHYL ALCOHOL 100%INJECTABLE 10 ML, 100 ML, 20 ML, 40 ML, 5 ML, 60 ML; ETHYL ALCOHOL 20% INJECTABLE 5 ML; ETHYL ALCOHOL 5% INJECTABLE 180 ML, 30 ML; ETHYL ALCOHOL

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 17 units units
FDA Drug Class II Terminated

ALTEPLASE, SDPF - (0.05ML SYRINGE, 30G, 1/2") 1000MCG/ML INJECTABLE 0.05 ML; ALTEPLASE, SDPF - (0.15ML LL SYRINGE, NO NEEDLE) 100MCG/ML (10MCG/0.1ML) INJECTA 0.15 ML, 0.3 ML; ALTEPLASE, SDPF - (0.1ML

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 16 units units
FDA Drug Class II Terminated

HYALURONIDASE / LIDOCAINE / BUPICAVAINE 7.1U/9.5MG/3.5MG/ML INJECTABLE 210 ML, 525 ML, 630 ML; HYALURONIDASE/LIDOCAINE/EPI/BUPIVICAINE INJECTABLE 32 ML, 64 ML (5 DIFFERENT PRODUCTS)

May 25, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 9 units units
FDA Drug Class II Terminated

LIDOCAINE HCL (STERILE) 4% JELLY 120 ML 30 ML; LIDOCAINE HCL 4% SOLUTION 200 ML 300 ML 500 ML 600 ML; LIDOCAINE HCL 1% INJECTABLE 100 ML 1000 ML

May 21, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 434 units units
FDA Drug Class II Terminated

MANNITOL 20% INJECTABLE 1250 ML 250 ML 2500 ML 400 ML; MANNITOL 25% INJECTABLE 1200 ML 300 ML 350 ML 400 ML 600 ML (9 DIFFERENT PRODUCTS)

May 21, 2012 Franck's Lab Inc., d.b.a. Franck's Compounding Lab 17 units units

Related Categories